Analyzers, Laboratory, Hematology, Blood/Component Volume

Definition : Hematology analyzers designed to measure total blood and/or some of its components (e.g., plasma and red cell) volume in a person's circulatory system; the devices can also determine the normal quantity of blood that an individual should have according to his/her body size. The measurements are based on the time rate of disappearance of a radioactive tracer (e.g., iodine isotope 131, I131) that is typically attached to albumin (the most abundant blood protein). A small amount of tracer is injected through an intravenous line using a special, pre-filled, small, and calibrated syringe. Typically five samples are collected using a standard blood collection setup in five- to six-minute intervals after an initial waiting period of 10 to 12 minutes. Blood/component volume measuring analyzers are intended for use after sudden blood loss (e.g., hemorrhage, surgery); they may be used also for blood donors and in patients suffering from renal and/or heart failures.

Entry Terms : "Red Blood Cell Volume Measuring Devices" , "Plasma Volume Measuring Devices" , "Blood Component Volume Analyzers" , "Blood Volume Measuring Devices" , "Blood Volume Analyzers"

UMDC code : 20664

U.S.companies only
Suppress Subsidiary Companies

1-2 of 2 Match(es).

Daxor Corp

Company Type: Parent

DAXOR Corporation is an innovative medical instrumentation and biotechnology company. We manufacture the BVA-100 Blood Volume Analyzer, the first instrument approved by the FDA to provide rapid direct measurement of a patient's blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential to transform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility. The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.

Transonic Systems Inc

Company Type: Parent

Founded in 1983, Transonic SystemsTM is the industry leader in biomedical flow measurement innovation & quality. Our transit-time ultrasound and ultrasound dilution technologies are the recognized gold standards in cardiovascular surgery, research and hemodialysis.

1-2 of 2 Match(es).


Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs
Medical Product Guide Cancer Therapy Advisor Product Zone